+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Urolithiasis Management Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 198 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336626
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Urolithiasis Management Devices Market is evolving rapidly, driven by ongoing advancements in minimally invasive technologies, growing procedural demand, and changing regulatory dynamics. As senior decision-makers seek actionable strategies for growth and risk mitigation, this report provides a holistic view tailored to the unique challenges and opportunities of the urolithiasis device landscape.

Market Snapshot: Urolithiasis Management Devices Market Insights

The Urolithiasis Management Devices Market grew from USD 490.76 million in 2024 to USD 527.03 million in 2025, with a projected CAGR of 7.93% and expectations to reach USD 903.70 million by 2032.

This strong growth reflects increasing prevalence of urinary stone disease, a rising preference for device-based interventions, and the adoption of advanced treatment modalities across global healthcare systems. Senior leaders can leverage this momentum to inform product development and market entry strategies.

Scope & Segmentation

  • Device Types: Guidewires, Lithotripters, Stents, Ureteroscopes
  • Treatment Types: Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy
  • Device Materials: Metal-Based Devices, Polymer-Based Devices
  • Applications: Bladder Stones, Kidney Stones, Ureteral Stones
  • End Users: Ambulatory Surgical Centers, Hospitals, Specialty Clinics
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru) Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya) Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
  • Key Companies: Advanced MedTech Holdings, AKSM Ltd., Avvio Medical, Becton Dickinson and Company, Boston Scientific Corporation, Calyxo Inc., Coloplast A/S, Cook Group, DirexGroup, Dornier MedTech, Dyne Medical Group, EMS Electro Medical Systems SA, EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia Inc., Karl Storz, Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, Teleflex Incorporated

Key Takeaways for Senior Market Leaders

  • Device innovation is reshaping treatment paradigms, with minimally invasive, endoscopic, and laser-based systems delivering improved precision and patient comfort.
  • Next-generation guidewires and biocompatible stents improve procedural workflow, postoperative outcomes, and drive differentiation in competitive tenders.
  • Regional dynamics matter; strong adoption and reimbursement in the United States and Western Europe contrast with emerging infrastructure in Asia-Pacific and the Middle East.
  • Collaborative partnerships between device manufacturers, academic institutions, and healthcare providers support cross-disciplinary innovation and accelerate market entry.
  • User-centric design and workflow integration are increasingly prioritized, influencing buyer preferences at both the clinical and administrative levels.
  • Value-based procurement and real-world clinical evidence play a growing role in shaping device selection and reimbursement pathways.

Tariff Impact and Supply Chain Challenges

Recent U.S. tariff measures on imported medical devices have increased procurement costs for essential components, such as polymers and specialized electronics. Manufacturers now face elevated expenses, extended lead times, and the need for greater inventory buffers. Supply chain resilience is addressed by nearshoring production, diversifying supplier networks, and negotiating preferential agreements to minimize disruptions and ensure competitive device availability to healthcare providers globally.

Methodology & Data Sources

This report integrates rigorous secondary research from peer-reviewed journals, clinical trial registries, regulatory databases, and policy documents. Primary interviews with urologists, procurement managers, and device engineers provide market granularity and real-world perspectives. Data validation includes cross-referencing multiple sources, with a multidisciplinary team ensuring analytical accuracy and consistency.

Why This Report Matters

  • Enables senior leaders to benchmark product portfolios, anticipate regulatory shifts, and assess the commercial impact of new technologies in urolithiasis management.
  • Supports informed investment and procurement choices by analyzing evolving reimbursement models and global supply chain considerations.
  • Delivers actionable insights into regional market dynamics and competitive strategies for targeted business growth.

Conclusion

As the urolithiasis management device market advances, stakeholders who align innovation with operational resilience and regulatory awareness will secure stronger positioning. This report provides the foundation for strategic planning and future-proof decision-making in a changing healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Growing integration of artificial intelligence algorithms for automated kidney stone detection and treatment planning
5.2. Surge in demand for single-use disposable ureteroscopes to reduce cross-contamination risks
5.3. Advancements in ultrasonic and laser lithotripsy technologies for faster stone fragmentation
5.4. Expansion of telemedicine and remote patient monitoring for post-operative urolithiasis care
5.5. Development of bioresorbable stents to minimize patient discomfort and reduce secondary procedures
5.6. Rising investments in portable ultrasound-guided lithotripsy devices for point-of-care applications
5.7. Increasing focus on personalized treatment pathways through 3D-printed patient-specific kidney models
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Urolithiasis Management Devices Market, by Device Type
8.1. Guidewires
8.2. Lithotripters
8.3. Stents
8.4. Ureteroscopes
9. Urolithiasis Management Devices Market, by Treatment Type
9.1. Extracorporeal Shock Wave Lithotripsy
9.2. Intracorporeal Lithotripsy
9.3. Percutaneous Nephrolithotomy
10. Urolithiasis Management Devices Market, by Device Material
10.1. Metal-Based Devices
10.2. Polymer-Based Devices
11. Urolithiasis Management Devices Market, by Application
11.1. Bladder Stones
11.2. Kidney Stones
11.3. Ureteral Stones
12. Urolithiasis Management Devices Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Specialty Clinics
13. Urolithiasis Management Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Urolithiasis Management Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Urolithiasis Management Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced MedTech Holdings
16.3.2. AKSM, Ltd.
16.3.3. Avvio Medical, Inc.
16.3.4. Becton, Dickinson and Company
16.3.5. Boston Scientific Corporation
16.3.6. Calyxo Inc.
16.3.7. Coloplast A/S
16.3.8. Cook Group Incorporated
16.3.9. DirexGroup
16.3.10. Dornier MedTech GmbH
16.3.11. Dyne Medical Group Inc.
16.3.12. E.M.S. Electro Medical Systems S.A.
16.3.13. EDAP TMS SA
16.3.14. Elmed Lithotripsy Systems
16.3.15. EndoTheia, Inc.
16.3.16. Karl Storz GmbH & Co. KG
16.3.17. Nissha Medical Technologies
16.3.18. Olympus Corporation
16.3.19. Quanta System S.p.A.
16.3.20. Richard Wolf GmbH
16.3.21. Siemens Healthineers
16.3.22. SonoMotion
16.3.23. Teleflex Incorporated

Companies Mentioned

The companies profiled in this Urolithiasis Management Devices market report include:
  • Advanced MedTech Holdings
  • AKSM, Ltd.
  • Avvio Medical, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Calyxo Inc.
  • Coloplast A/S
  • Cook Group Incorporated
  • DirexGroup
  • Dornier MedTech GmbH
  • Dyne Medical Group Inc.
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Elmed Lithotripsy Systems
  • EndoTheia, Inc.
  • Karl Storz GmbH & Co. KG
  • Nissha Medical Technologies
  • Olympus Corporation
  • Quanta System S.p.A.
  • Richard Wolf GmbH
  • Siemens Healthineers
  • SonoMotion
  • Teleflex Incorporated

Table Information